Picture of Maravai Lifesciences Holdings logo

MRVI — Maravai Lifesciences Holdings News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Maravai LifeSciences Holdings Inc reports results for the quarter ended in June - Earnings Summary

* Maravai LifeSciences Holdings Inc  MRVI.OQ  reported
quarterly
breakeven results​​ per share for the quarter ended in June. The
mean expectation of twelve analysts for the quarter was
for earnings of one cent per share.
    * Revenue fell 71.6% to $68.91 million from a year ago;
analysts
expected $71.13 million. 
    * Maravai LifeSciences Holdings Inc's reported EPS for the
quarter
was a loss of 5 cents​.
    * The mean earnings estimate of analysts had fallen by
about 70.9%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate 
    * Maravai LifeSciences Holdings Inc shares had fallen
by 7.5% this
quarter and lost 19.6% so far this year.
    * The company reported a quarterly loss of $6.54 million.
    * Wall Street's median 12-month price target for Maravai
LifeSciences Holdings Inc is $18.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 7 at 10:05 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      0.01           0.00           Missed
 Mar. 31 2023      0.04           0.03           Missed
 Dec. 31 2022      0.34           0.35           Beat
 Sep. 30 2022      0.33           0.37           Beat

Recent news on Maravai Lifesciences Holdings

See all news